Jia-Rong Wu1, Debra K Moser2. 1. College of Nursing, University of Kentucky, Lexington, Kentucky. Electronic address: jiarong.wu2@uky.edu. 2. College of Nursing, University of Kentucky, Lexington, Kentucky.
Abstract
BACKGROUND: Health-related quality of life (HRQOL) is an important patient-reported outcome that is related to medication adherence, hospitalization and death. The nature of the relationships among medication adherence, HRQOL, and hospitalization and death is unknown. We sought to determine the relationships among medication adherence, HRQOL, and cardiac event-free survival in patients with heart failure. METHODS AND RESULTS: We enrolled 218 patients with heart failure. Patients' medication adherence was measured objectively using the Medication Event Monitoring System. HRQOL was assessed using the Minnesota Living with Heart Failure Questionnaire. Patients were followed for up to 3.5 years to collect hospitalization and mortality data. Mediation analysis was used to determine the nature of the relationships among the variables. Patients with better medication adherence had better HRQOL (P = .014). Medication adherence and HRQOL were associated with cardiac event-free survival (both P < .05). Patients with medication nonadherence were 1.86 times more likely to experience a cardiac event than those with better medication adherence (P = .038). Medication adherence was not associated with cardiac event-free survival after entering HRQOL in the model (P = .118), indicating mediation by HRQOL of the relationship between medication adherence and cardiac event-free survival. CONCLUSIONS: HRQOL mediated the relationship between medication adherence and cardiac event-free survival. It is important to assess medication adherence and HRQOL regularly and develop interventions to improve medication adherence and HRQOL to decrease hospitalization and mortality in patients with heart failure.
BACKGROUND: Health-related quality of life (HRQOL) is an important patient-reported outcome that is related to medication adherence, hospitalization and death. The nature of the relationships among medication adherence, HRQOL, and hospitalization and death is unknown. We sought to determine the relationships among medication adherence, HRQOL, and cardiac event-free survival in patients with heart failure. METHODS AND RESULTS: We enrolled 218 patients with heart failure. Patients' medication adherence was measured objectively using the Medication Event Monitoring System. HRQOL was assessed using the Minnesota Living with Heart Failure Questionnaire. Patients were followed for up to 3.5 years to collect hospitalization and mortality data. Mediation analysis was used to determine the nature of the relationships among the variables. Patients with better medication adherence had better HRQOL (P = .014). Medication adherence and HRQOL were associated with cardiac event-free survival (both P < .05). Patients with medication nonadherence were 1.86 times more likely to experience a cardiac event than those with better medication adherence (P = .038). Medication adherence was not associated with cardiac event-free survival after entering HRQOL in the model (P = .118), indicating mediation by HRQOL of the relationship between medication adherence and cardiac event-free survival. CONCLUSIONS: HRQOL mediated the relationship between medication adherence and cardiac event-free survival. It is important to assess medication adherence and HRQOL regularly and develop interventions to improve medication adherence and HRQOL to decrease hospitalization and mortality in patients with heart failure.
Authors: Sarah M Khayyat; Mahmoud M A Mohamed; Salwa M Saeed Khayyat; Raghda S Hyat Alhazmi; Mulham Fouad Korani; Ebtesam Bakheet Allugmani; Sarah Fathallah Saleh; Deyaa Abdulla Mansouri; Qasim A Lamfon; Osama Mohammed Beshiri; Muhammad Abdul Hadi Journal: Qual Life Res Date: 2018-11-23 Impact factor: 4.147
Authors: Salim S Virani; Alvaro Alonso; Emelia J Benjamin; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Amanda Marma Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Christina M Shay; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Lisa B VanWagner; Connie W Tsao Journal: Circulation Date: 2020-01-29 Impact factor: 29.690
Authors: Amrut V Ambardekar; Gregg C Fonarow; Adrian F Hernandez; Wenqin Pan; Clyde W Yancy; Mori J Krantz Journal: Am Heart J Date: 2009-10 Impact factor: 4.749
Authors: Debra K Moser; Laura Yamokoski; Jie Lena Sun; Ginger A Conway; Karen A Hartman; Judith A Graziano; Cynthia Binanay; Lynne W Stevenson Journal: J Card Fail Date: 2009-06-25 Impact factor: 5.712
Authors: Misook L Chung; Terry A Lennie; Marla de Jong; Jia-Rong Wu; Barbara Riegel; Debra K Moser Journal: J Card Fail Date: 2008-03 Impact factor: 5.712
Authors: Benjamin Van Tassell; Virginia Mihalick; Georgia Thomas; Amr Marawan; Azita H Talasaz; Juan Lu; Le Kang; Amy Ladd; Juan Ignacio Damonte; Dave L Dixon; Roshanak Markley; Jeremy Turlington; Emily Federmann; Marco Giuseppe Del Buono; Giuseppe Biondi-Zoccai; Justin M Canada; Ross Arena; Antonio Abbate Journal: J Transl Med Date: 2022-06-15 Impact factor: 8.440